Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia
Monica Fung(University of California, San Francisco), Sophia Koo(Dana-Farber Brigham Cancer Center), Francisco M. Marty(Brigham and Women's Hospital), Michaël Schwarzinger(Université de Bordeaux), Jane Kim(Stanford University)
Cited by 59
Related Papers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
COVID-19 in Immunocompromised Hosts: What We Know So Far
|Clinical Infectious Diseases|2020|568
Integrating host response and unbiased microbe detection for lower respiratory tract infection diagnosis in critically ill adults
|Proceedings of the National Academy of Sciences|2018|434
Breakthrough Zygomycosis after Voriconazole Treatment in Recipients of Hematopoietic Stem-Cell Transplants
|New England Journal of Medicine|2004|425
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
|Clinical Infectious Diseases|2021|299